OMNIPAQUE 180
GE HEALTHCARE CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is OMNIPAQUE 180 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that OMNIPAQUE 180 388MG has been permanently discontinued (last updated February 22, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is OMNIPAQUE 180 not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
OMNIPAQUE 180 LIQ SAR 388MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 350
GE HEALTHCARE CANADA INC
OMNIPAQUE 300
GE HEALTHCARE CANADA INC
OMNIPAQUE 240 LIQ IV SAR 518MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 300 LIQ IV SAR 647MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 350 LIQ IV 755MG/ML
SANOFI CANADA, INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02172720
Strength
388MG
Dosage Form
SOLUTION
Route
SUBARACHNOIDAL
Active Ingredient
IOHEXOL
Tier
Unrated
Last Updated
2023-02-22
Reason for Shortage
Business reasons
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.